CPL Launches Production of Hand-Sanitizer to Meet Critical Shortages

Contract Pharmaceuticals Limited Canada (CPL), a Health Canada and U.S. FDA inspected manufacturer of liquid and semi-solid prescription and OTC medicines, has begun production of its alcohol-based hand sanitizer to help meet the current market shortage during the ongoing COVID-19 pandemic.
 
With the urgent need for hand sanitizer, CPL recently developed its product based on Health Canada and FDA guidelines. The first approved product is a hand sanitizer solution containing 80% alcohol in 60mL and 200mL bottles. CPL is currently manufacturing the product at its manufacturing and packaging operation in Mississauga, Ontario, Canada. While some input materials are in short supply, CPL said it is working with its supplier partners to find ways to ramp production quickly.
 
"CPL is one of the leading contract manufacturers of non-sterile liquid and topical prescription and OTC products in North America, and one of few companies that have the proper equipment to safely manufacture alcohol-containing products," said Jan Sahai, vice president, business development, CPL. "As we saw the market shortages unfold, we developed formulas for hand sanitizer solution and gel products, registered the products with Health Canada, and began manufacturing, packaging and testing the first products within the past few weeks."
 
The company is currently shipping the product across Canada to long-term care facilities, grocery store distribution centers, universities, and a variety of essential industries. "Many of these organizations are desperate for hand sanitizer products as the demand is great during this crisis," said Sahai. "We are simply trying to do our part in this fight, and in support of our collective effort we will donate a portion of our production to organizations most in need."
 

CPhI China 2020 To Be Postponed to Dec. 16-18th,

Register as Visitor to the 20th Edition of CPhI China!

-----------------------------------------------------------------------
Editor's Note:

En-CPhI.CN is a vertical B2B online trade platform serving the pharmaceutical industry,

for any copyright disputes involved in the articles,

please email: Julia.Zhang@imsinoexpo.com to motify or remove the content.